Free Trial

Acutus Medical Q2 2023 Earnings Report

Acutus Medical logo
$0.05 0.00 (-7.59%)
As of 02/21/2025 03:54 PM Eastern

Acutus Medical EPS Results

Actual EPS
-$0.63
Consensus EPS
-$0.61
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Acutus Medical Revenue Results

Actual Revenue
$5.29 million
Expected Revenue
$4.60 million
Beat/Miss
Beat by +$690.00 thousand
YoY Revenue Growth
N/A

Acutus Medical Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Acutus Medical Earnings Headlines

Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.
See More Acutus Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Acutus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acutus Medical and other key companies, straight to your email.

About Acutus Medical

Acutus Medical (NASDAQ:AFIB) designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

View Acutus Medical Profile

More Earnings Resources from MarketBeat